|
Originally published In Press as doi:10.1194/jlr.M400250-JLR200 on September 1, 2004
Journal of Lipid Research, Vol. 45, 2303-2309, December 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample
Minna T. Jänis*,
Sarah Siggins*,
Esa Tahvanainen*,
Riikka Vikstedt*,
Kaisa Silander*,
Jari Metso*,
Arpo Aromaa ,
Marja-Riitta Taskinen ,
Vesa M. Olkkonen*,
Matti Jauhiainen* and
Christian Ehnholm1,*
* Department of Molecular Medicine, National Public Health Institute, Biomedicum, Helsinki, Finland
Department of Health and Functional Capacity, National Public Health Institute, Biomedicum, Helsinki, Finland
Division of Cardiology, Department of Medicine, University of Helsinki, Helsinki, Finland
1 To whom correspondence should be addressed. e-mail: christian.ehnholm{at}ktl.fi
Human serum phospholipid transfer protein (PLTP) exists as a catalytically active (HA-PLTP) and a low-active (LA-PLTP) form. In this study, the association of PLTP activity and the concentrations of both forms with lipid and carbohydrate parameters were investigated. In a random Finnish population sample, serum PLTP concentration (n = 250) was 6.56 ± 1.45 mg/l, the mean lipoprotein-independent (PLTPexo) phospholipid transfer activity was 6.59 ± 1.66 µmol/ml/h, and the mean lipoprotein-dependent (PLTPendo) activity was 1.37 ± 0.29 µmol/ml/h. Of the serum PLTP concentration, 46% was in a catalytically active form. HA-PLTP concentration correlated positively with serum PLTPexo activity (r = 0.380, P < 0.001), HDL cholesterol (r = 0.291, P < 0.001), and apolipoprotein A-I (r = 0.187, P < 0.01). Of the potential regulatory factors for PLTP, apolipoprotein E showed a weak positive correlation with serum PLTPexo (r = 0.154, P < 0.05) and PLTPendo (r = 0.192, P < 0.01) activity but not with PLTP concentration. Weak associations were also observed between PLTP parameters and determinants of glucose homeostasis (glucose, insulin, and homeostasis model assessment for insulin resistance).
The present data on PLTP activity and concentration reveal novel connections of the two PLTP forms to lipid and carbohydrate metabolism.
Abbreviations: apoB, apolipoprotein B; BMI, body mass index; CRP, C-reactive protein; CV, coefficient of variation; HA, high-active form; HDL-C, HDL-cholesterol; HOMA IR, homeostasis model assessment for insulin resistance; LA, low-active form; LDL-C, LDL-cholesterol; PLTP, phospholipid transfer protein; TC, total cholesterol; TG, triglyceride; WHR, waist-to-hip ratio Supplementary key words apolipoproteins lipid transfer proteins enzyme-linked immunosorbent assay

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Vikstedt, D. Ye, J. Metso, R. B. Hildebrand, T. J.C. Van Berkel, C. Ehnholm, M. Jauhiainen, and M. Van Eck
Macrophage Phospholipid Transfer Protein Contributes Significantly to Total Plasma Phospholipid Transfer Activity and Its Deficiency Leads to Diminished Atherosclerotic Lesion Development
Arterioscler Thromb Vasc Biol,
March 1, 2007;
27(3):
578 - 586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soderlund, A. Soro-Paavonen, C. Ehnholm, M. Jauhiainen, and M.-R. Taskinen
Hypertriglyceridemia is associated with pre{beta}-HDL concentrations in subjects with familial low HDL
J. Lipid Res.,
August 1, 2005;
46(8):
1643 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|